Back to UBS Group AG UBS Group AG

BIOBIO
Showing 8 of 29 quarters

Position history for UBS Group AGUBS Group AG's holdings in BIO RAD LABS INC

UBS Group AG holds 354,365 shares of BIO (BIO RAD LABS INC), worth $98.8M as of 2026-Q1. The position was increased (+63.9% shares). BIO represents 0.0% of UBS Group AG's portfolio.

Current Value

$98.8M

Current Shares

354,365

Total Value Change

+$84.3M

Total Shares Change

+301,455

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
354,365
+63.9%
$98.8M0.0%$280.19
44
2025-Q4
Decreased
216,186
-6.3%
$65.5M0.0%$304.51
0
2025-Q3
Increased
230,719
+14.9%
$64.7M0.0%$270.11
34
2025-Q2
Decreased
200,764
-7.8%
$48.4M0.0%$243.98
0
2025-Q1
Increased
217,636
+174.5%
$53M0.0%$243.00
47
2024-Q4
Increased
79,286
+171.3%
$26M0.0%$326.34
46
2024-Q3
Decreased
29,227
-44.8%
$9.8M0.0%$331.77
0
2024-Q2
Decreased
52,910
-0.7%
$14.5M0.0%$273.11
0

Other major holders of BIO: First Eagle Investment Management, LLC, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used